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During 2013–2016, we isolated blaNDM- and blaVIM-harbor-
ing Enterobacteriaceae and nonfermentative bacteria from 
patients in the Philippines. Of 130 carbapenem-resistant 
isolates tested, 45 were Carba NP–positive; 43 harbored 
blaNDM, and 2 harbored blaVIM. Multidrug-resistant microbial 
pathogen surveillance and antimicrobial drug stewardship 
are needed to prevent further spread of New Delhi metallo-
β-lactamase variants.
Carbapenemase-producing Enterobacteriaceae can ef-ficiently hydrolyze carbapenems and most β-lactam 
drugs. Since the identification of New Delhi metallo-β-
lactamase-1 (NDM-1) in 2008 (1), there has been great 
concern regarding the spread of the Ambler class B 
metallo-β-lactamases (MBLs). Confirmed infections with 
MBL-positive bacteria are rarely identified in the Philip-
pines, but blaIMP-harboring Enterobacteriaceae were re-
ported in 2014 (2), an Escherichia coli (sequence type 
[ST] 131) isolate harboring blaNDM-1 was reported in 2014 
(3), and 2 Klebsiella pneumoniae (ST626 and ST903) iso-
lates harboring blaNDM-1 and blaNDM-7 genes were reported 
in 2016 (4).
We performed isolate identification and antimicrobial 
drug susceptibility testing by using the MicroScan Walk-
Away 40 plus System (Beckman Coulter, Brea, CA, USA) 
on 1,516 gram-positive and gram-negative isolates from 
patients admitted to various wards in the V. Luna Medi-
cal Center, a tertiary-care military hospital in Manila, the 
Philippines, during August 2013–April 2016. To better 
assess the distribution of carbapenem resistance and the un-
derlying molecular mechanisms of resistance, we selected 
gram-negative isolates with imipenem or meropenem (or 
both) MICs of >8 µg/mL. We used microbroth dilution sus-
ceptibility testing (5) to select and verify 130 gram-nega-
tive nonrepeat isolates (i.e., each isolate was tested once) 
and then tested the isolates for carbapenemase production 
by using the Carba NP test as previously described (6). 
We tested all isolates with a Carba NP–positive result for 
blaNDM and blaKPC by using a multiplex real-time PCR assay 
as previously described (7,8); isolates with PCR-negative 
results were further tested, using the Xpert Carba-R PCR 
test with the GeneXpert IV System (both from Cepheid, 
Sunnyvale, CA, USA), for the presence of blaNDM, blaKPC, 
blaVIM, blaIMP-1, and blaOXA-48.
Of the 130 bacterial isolates tested, 45 (35%) had posi-
tive Carba NP test results and 43 (33%) harbored blaNDM; 
25 (58%) of the blaNDM-carrying isolates were identified as 
K. pneumoniae (online Technical Appendix Table, https://
wwwnc.cdc.gov/EID/article/23/9/16-1237-Techapp1.pdf). 
None of the isolates was positive for blaKPC. Two Pseudo-
monas aeruginosa isolates that had positive Carba NP test 
results were negative for blaNDM and blaKPC but positive for 
blaVIM. During the collection period, we also tested 8 envi-
ronmental samples collected from the hospital’s neonatal 
intensive care unit and obstetrics and gynecology wards; 3 
(38%) of the 8 isolates were positive for blaNDM and identi-
fied as K. pneumoniae (online Technical Appendix Table).
We report the identification of blaNDM-positive bacte-
rial isolates in several genera of Enterobacteriaceae and 
nonfermentative bacteria in the Philippines. This finding is 
particularly significant because NDM-like enzymes have a 
broad range of activity against most β-lactam antimicrobial 
drugs and are often associated with serious clinical infec-
tions (9). A higher risk for plasmid-mediated transfer of 
NDM-1 exists through conjugation between different gram-
negative bacterial strains (10), and NDM-1 can spread rap-
idly via nosocomial transmission or community-acquired 
infection. Furthermore, although limited in number, the 
environmental samples in this study were also positive for 
blaNDM, which suggests the possibility of nosocomial trans-
mission and local circulation. 
We conducted multiplex real-time PCR testing only 
for blaNDM, blaKPC, blaVIM, blaIMP-1, and blaOXA-48 and did 
not investigate clonality; thus, further investigation into 
other carbapenemase genes should be conducted. In ad-
dition, further experiments should be performed to char-
acterize the plasmids carrying the carbapenemase genes. 
Strengthening of multidrug-resistant microbial pathogen 
surveillance and antimicrobial drug stewardship is urgent-
ly needed to better characterize drug-resistance patterns 
and improve early detection and containment strategies in 
developing countries.
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Human and mouse prion proteins share a structural motif 
that regulates resistance to common chronic wasting dis-
ease (CWD) prion strains. Successful transmission of an 
emergent strain of CWD prion, H95+, into mice resulted 
in infection. Thus, emergent CWD prion strains may have 
higher zoonotic potential than common strains.
Chronic wasting disease (CWD) is a contagious prion disease of cervids that is spreading globally. CWD is 
enzootic in multiple cervid species, including deer and elk; 
the major foci of disease are Colorado/Wyoming (USA), 
Wisconsin/Illinois (USA), and Alberta/Saskatchewan (Can-
ada). CWD is also present in captive cervids in South Korea 
and wild reindeer and moose in Norway (https://www.nwhc.
usgs.gov/images/cwd/cwd_map.jpg). CWD results from the 
conformational transformation of the host-encoded cellular 
prion protein (PrPC) into protease-resistant, detergent-insol-
uble, β-sheet rich, amyloidogenic conformers, termed prions 
(PrPCWD). Within their conformation, prion strains encipher 
the information that directs the templated misfolding and ag-
gregation of PrPC molecules into additional prions (1).
Although the sequence homology of PrP among mam-
mals is high, the ability of particular prion strains to cause dis-
ease in different species is determined by the conformational 
compatibility between a given strain and the host PrPC (2). We 
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